Latest News

Chemohyperthermia with Mitomycin C and COMBAT system in High Risk Non-Muscle Invasive Bladder Cancer patients: Initial experience in a single center

More

Quality of life (QoL), Non Muscle Invasive Bladder Cancer (NMIBC) and Endovesical Treatments: Instillation matters.

More

The role of conductive hyperthermia with mitomycin in High Risk Non Muscle Invasive Bladder Cancer that has failed BCG therapy

More

Hyperthermic intravesical chemotherapy for BCG-unresponsive or BCG ineligible non-muscle invasive bladder cancer patients

More

Global Congress on Bladder Cancer 5-6th October 2017

Combat Medical are exhibiting at the Global Congress on Bladder Cancer- Edinburgh. 4 abstracts will

More

BAUS Annual Scientific Meeting (Glasgow 2017) 26 Jun – 28 Jun 2017

We will once again be attending and exhibiting at the forthcoming annual BAUS Conference in

More

European Society of Hyperthermic Oncology – ESHO Athens-Greece, June 21 – 23, 2017.

We will be attending and exhibiting at the forthcoming ESHO meeting in Athens on 21-23rd

More

ENFURO Congress – Spain

As usage with the COMBAT BRS system grows, more hospitals are beginning to publish and

More

National Urology Congress- Sevilla, Spain LXXXII Congreso Nacional de Urología, Sevilla, 7 al 10 de junio de 2017

It has been a busy time for Combat in Spain, and last week, in partnership

More

National Urology Conference – Pisa, Italy

Combat Medical Ltd recently attended the national meeting in Pisa Italy, during which time, Ms

More